These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2086618)

  • 1. Treatment of cutaneous T-cell lymphomas (CTCL) with extracorporeal photochemotherapy--preliminary report.
    Nagatani T; Matsuzaki T; Kim S; Baba N; Osawa J; Sugiyama A; Komatsu H; Ichiyama S; Takahashi Y; Miyamoto H
    J Dermatol; 1990 Dec; 17(12):737-45. PubMed ID: 2086618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
    J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular mycosis fungoides.
    Klemke CD; Dippel E; Assaf C; Hummel M; Stein H; Goerdt S; Orfanos CE
    Br J Dermatol; 1999 Jul; 141(1):137-40. PubMed ID: 10417530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlormethine Gel for the Treatment of Mycosis Fungoides (Cutaneous T-cell Lymphoma) in Canada.
    Gniadecki R; Paron E
    Skin Therapy Lett; 2023 Mar; 28(2):1-5. PubMed ID: 37054720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides.
    Fimiani M; Rubegni P; Pimpinelli N; Mori M; De Aloe G; Andreassi L
    Dermatology; 1997; 194(2):107-10. PubMed ID: 9094456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular cutaneous T-cell lymphoma: a clinicopathological study of nine cases.
    Hodak E; Feinmesser M; Segal T; Yosipovitch G; Lapidoth M; Maron L; Bergman R; Sahar D; David M
    Br J Dermatol; 1999 Aug; 141(2):315-22. PubMed ID: 10468808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
    Kim EJ; Mangold AR; DeSimone JA; Wong HK; Seminario-Vidal L; Guitart J; Appel J; Geskin L; Lain E; Korman NJ; Zeitouni N; Nikbakht N; Dawes K; Akilov O; Carter J; Shinohara M; Kuzel TM; Piette W; Bhatia N; Musiek A; Pariser D; Kim YH; Elston D; Boh E; Duvic M; Huen A; Pacheco T; Zwerner JP; Lee ST; Girardi M; Querfeld C; Bohjanen K; Olsen E; Wood GS; Rumage A; Donini O; Haulenbeek A; Schaber CJ; Straube R; Pullion C; Rook AH; Poligone B
    JAMA Dermatol; 2022 Sep; 158(9):1031-1039. PubMed ID: 35857290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
    Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
    J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photochemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages. A quantitative histological study.
    Miracco C; Rubegni P; De Aloe G; D'Ascenzo G; Mazzatenta C; De Santi MM; Fimiani M
    Br J Dermatol; 1997 Oct; 137(4):549-57. PubMed ID: 9390330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilesional mycosis fungoides treated with photodynamic therapy. A case report.
    Hegyi J; Frey T; Arenberger P
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Jun; 17(2):75-8. PubMed ID: 18709294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
    Kannangara AP; Levitan D; Fleischer AB
    J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
    Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
    Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.
    Scarisbrick JJ; Child FJ; Clift A; Sabroe R; Whittaker SJ; Spittle M; Russell-Jones R
    Br J Dermatol; 2001 May; 144(5):1010-5. PubMed ID: 11359390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant.
    Heald PW; Glusac EJ
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):283-5. PubMed ID: 10642687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
    Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
    Quaglino P; Fierro MT; Rossotto GL; Savoia P; Bernengo MG
    Br J Dermatol; 2004 Feb; 150(2):327-36. PubMed ID: 14996105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photochemotherapy for mycosis fungoides.
    Roenigk HH
    Arch Dermatol; 1977 Aug; 113(8):1047-51. PubMed ID: 889332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.